These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1807 related articles for article (PubMed ID: 19447039)

  • 1. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxicity and protein kinase C inhibition of arylpyrrolylmaleimides.
    Xu GQ; Zhang C; Zhang L; Zhou XL; Yang B; He QJ; Hu YZ
    Arch Pharm (Weinheim); 2008 May; 341(5):273-80. PubMed ID: 18404777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxicity of novel 3-amino-4-indolylmaleimide derivatives.
    Zhao SY; Yang YW; Zhang HQ; Yue Y; Fan M
    Arch Pharm Res; 2011 Apr; 34(4):519-26. PubMed ID: 21544716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
    Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
    Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indolylmaleimide derivatives.
    Dodo K; Katoh M; Shimizu T; Takahashi M; Sodeoka M
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3114-8. PubMed ID: 15878276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.
    Wang K; Liu ZZ
    J Asian Nat Prod Res; 2014; 16(3):296-303. PubMed ID: 24456252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
    Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
    Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
    More KN; Jang HW; Hong VS; Lee J
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2424-8. PubMed ID: 24775304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of functionalized isoindigos as antiproliferative agents.
    Wee XK; Yeo WK; Zhang B; Tan VB; Lim KM; Tay TE; Go ML
    Bioorg Med Chem; 2009 Nov; 17(21):7562-71. PubMed ID: 19783149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of EGFR tyrosine kinase inhibition by C-C multiple bonds-containing anilinoquinazolines.
    Ban HS; Tanaka Y; Nabeyama W; Hatori M; Nakamura H
    Bioorg Med Chem; 2010 Jan; 18(2):870-9. PubMed ID: 19969465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
    Wang K; Li XY; Chen XG; Liu ZZ
    J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
    Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
    Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.
    Mannion M; Raeppel S; Claridge S; Zhou N; Saavedra O; Isakovic L; Zhan L; Gaudette F; Raeppel F; Déziel R; Beaulieu N; Nguyen H; Chute I; Beaulieu C; Dupont I; Robert MF; Lefebvre S; Dubay M; Rahil J; Wang J; Ste-Croix H; Robert Macleod A; Besterman JM; Vaisburg A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6552-6. PubMed ID: 19854051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
    Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
    Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.